BlackRock Inc. - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 108 filers reported holding ALBIREO PHARMA INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$29,063,224
+23.5%
1,344,897
+10.7%
0.00%0.0%
Q3 2022$23,530,000
-2.3%
1,215,406
+0.2%
0.00%0.0%
Q2 2022$24,081,000
-29.9%
1,212,620
+5.4%
0.00%0.0%
Q1 2022$34,334,000
+26.1%
1,151,032
-1.5%
0.00%0.0%
Q4 2021$27,221,000
-24.6%
1,168,783
+1.0%
0.00%0.0%
Q3 2021$36,093,000
-14.4%
1,156,866
-3.5%
0.00%0.0%
Q2 2021$42,174,000
-6.4%
1,198,822
-6.2%
0.00%0.0%
Q1 2021$45,075,000
-3.3%
1,278,734
+2.9%
0.00%0.0%
Q4 2020$46,617,000
+49.1%
1,242,780
+32.6%
0.00%0.0%
Q3 2020$31,273,000
+29.8%
937,156
+3.0%
0.00%0.0%
Q2 2020$24,089,000
+91.5%
909,429
+18.3%
0.00%0.0%
Q1 2020$12,582,000
-30.2%
768,623
+8.4%
0.00%0.0%
Q4 2019$18,033,000
+33.5%
709,381
+5.0%
0.00%0.0%
Q3 2019$13,509,000
-36.4%
675,465
+2.5%
0.00%0.0%
Q2 2019$21,239,000
+14.8%
658,767
+14.7%
0.00%0.0%
Q1 2019$18,495,000
+28.8%
574,192
-1.9%
0.00%0.0%
Q4 2018$14,362,000
-25.4%
585,501
+0.2%
0.00%0.0%
Q3 2018$19,255,000
+3.5%
584,177
+11.4%
0.00%0.0%
Q2 2018$18,611,000
+644.1%
524,276
+582.8%
0.00%
Q1 2018$2,501,000
+691.5%
76,780
+522.4%
0.00%
Q4 2017$316,000
+38.0%
12,336
+12.5%
0.00%
Q3 2017$229,000
+23.1%
10,961
+21.7%
0.00%
Q2 2017$186,000
+785.7%
9,006
+923.4%
0.00%
Q1 2017$21,0008800.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders